Malignant Colorectal Neoplasm — Research

Malignant Colorectal Neoplasm — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-13	169,282	`("Malignant Colorectal Neoplasm"[tiab] OR "Colorectal Cancer"[tiab] OR "Malignant Colorectal Tumor"[tiab])`	2026-09-13	pubmed
Last 5 years	2021-01-01 → 2026-12-31	65,243	`("Malignant Colorectal Neoplasm"[tiab] OR "Colorectal Cancer"[tiab] OR "Malignant Colorectal Tumor"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-13	pubmed
Last 12 months	2025-09-13 → 2026-09-13	14,135	`("Malignant Colorectal Neoplasm"[tiab] OR "Colorectal Cancer"[tiab] OR "Malignant Colorectal Tumor"[tiab]) AND (2025/09/13:2026/09/13[dp])`	2026-09-13	pubmed

Data updated 18 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (357)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 276–300 of 357 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.
· J Natl Cancer Inst · 2016 · PMID 26563355 · validated civic_curation pubmed
Larotrectinib in Mismatch-Repair-Deficient TRK Fusion-Positive Metastatic Colon Cancer After Progression on Immunotherapy.
· Cureus · 2022 · PMID 35815302 · validated civic_curation pubmed
HRAS G13D, a new mutation implicated in the resistance to anti-EGFR therapies in colorectal cancer, a case report.
· Int J Colorectal Dis · 2016 · PMID 26561417 · validated civic_curation pubmed
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.